Search
for
Sort by
Research 301–330 of 1000+
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier
- Cell death as an architect of adult skin stem cell niches
- Saponins of Paris polyphylla for the Improvement of Acne: Anti-Inflammatory, Antibacterial, Antioxidant and Immunomodulatory Effects
- Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Inflammasome Proteins as Biomarkers of Injury and Disease
- THE ROLE OF AGONISTS AND ANTAGONISTS OF THE WNT SIGNALING PATHWAY IN PATIENTS WITH ANDROGENIC ALOPECIA AND ALOPECIA AREATA
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Phospholipase A2 in skin biology: new insights from gene-manipulated mice and lipidomics
- Stem Cell Secretome for Skincare: Of Cell Types, Exosomes, Extracellular Vesicles, and Soluble Fractions
- Metabolic pathways of eicosanoids—derivatives of arachidonic acid and their significance in skin
- The skin mycobiome and intermicrobial interactions in the cutaneous niche
- Recurrent implantation failure: A comprehensive summary from etiology to treatment
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Mechanisms of autophagy and their implications in dermatological disorders
- Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
- The JAK/STAT signaling pathway: from bench to clinic
- The microbiome in patients with atopic dermatitis
- JAK inhibitors in dermatology: The promise of a new drug class
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Commensal Microbes and Hair Follicle Morphogenesis Coordinately Drive Treg Migration into Neonatal Skin
- Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Inflammatory priming enhances mesenchymal stromal cell secretome potential as a clinical product for regenerative medicine approaches through secreted factors and EV-miRNAs: the example of joint disease
- Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin